Opus Genetics, Inc.
IRD
$4.90
-$0.29-5.59%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -49.59M | -68.20M | -58.28M | -58.62M | -57.53M |
| Total Depreciation and Amortization | 53.00K | 50.00K | 37.00K | 23.00K | 10.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.44M | 36.11M | 26.48M | 27.34M | 28.86M |
| Change in Net Operating Assets | -2.15M | -817.00K | -74.00K | 2.40M | 3.09M |
| Cash from Operations | -35.25M | -32.86M | -31.83M | -28.85M | -25.58M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 1.21M | 1.21M | 1.21M | 1.21M |
| Cash from Investing | -- | 1.21M | 1.21M | 1.21M | 1.21M |
| Total Debt Issued | 1.00M | 1.00M | 1.00M | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 35.96M | 11.63M | 6.85M | 8.41M | 4.50M |
| Repurchase of Common Stock | -152.00K | -73.00K | -73.00K | -73.00K | -79.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 13.22M | 13.27M | 13.86M | 13.94M | -232.00K |
| Cash from Financing | 50.02M | 25.83M | 21.64M | 22.28M | 4.19M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.77M | -5.82M | -8.98M | -5.37M | -20.18M |